October 27, 2018
1 min watch
Save

VIDEO: Glaukos launches iStent inject at AAO

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

CHICAGO ― At the Ophthalmology Innovation Summit at AAO, Jane Rady, Glaukos senior vice president of corporate strategy and business development, discusses the launch of the iStent inject, the latest MIGS device to enter the market for the treatment of glaucoma.